I"ÿ=<h1 id="application">Application</h1>

<p><br /><br />
<strong>This page shows some of the applications of the collected ribozymes. We listed three kinds of applications, â€˜Gene Expression Systemâ€™, â€˜Detection Systemâ€™, and â€˜Gene Editing Systemâ€™ as shown in the following table. Two specific examples are also presented, as shown in the figures below.<strong>
<br /><br /></strong></strong></p>

<blockquote>
  <p>Gene Expression system</p>
</blockquote>

<p>Several ribozymes have been used for gene expression regulation. For instance, twister ribozyme can be engineered to the Tornado (â€˜Twister-optimized RNA for durable overexpressionâ€™) expression system for efficient expression of circular RNA. The hammerhead ribozyme was used to digest viral, oncogene or mutant mRNA. Other self-cleaving ribozymes have been designed to regulate gene expression in a ligand-dependent way.<br /></p>

<html>
<head>
	<meta http-equiv="Content-type" content="text/html; charset=utf-8" />
	<meta name="viewport" content="width=device-width,initial-scale=1,user-scalable=no" />
	<title>Ribozyme applications </title>
	<link rel="stylesheet" type="text/css" href="https://cdn.datatables.net/1.12.1/css/jquery.dataTables.min.css" />
	<link rel="stylesheet" type="text/css" href="https://cdn.datatables.net/buttons/2.2.3/css/buttons.dataTables.min.css" />
</head>
    <style>
		th {
        background-color: #005826;
        color: rgba(255,255,255,0.9);
		    cursor: pointer;
        }
	</style>
  <script type="text/javascript" src="https://code.jquery.com/jquery-3.5.1.js"></script>
	<script type="text/javascript" src="https://cdn.datatables.net/1.12.1/js/jquery.dataTables.min.js"></script>
	<script type="text/javascript" src="https://cdn.datatables.net/buttons/2.2.3/js/dataTables.buttons.min.js"></script>
	<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.1.3/jszip.min.js"></script>
	<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.1.53/pdfmake.min.js"></script>
	<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.1.53/vfs_fonts.js"></script>
	<script type="text/javascript" src="https://cdn.datatables.net/buttons/2.2.3/js/buttons.html5.min.js"></script>
	<script type="text/javascript" src="https://cdn.datatables.net/buttons/2.2.3/js/buttons.print.min.js"></script>
	<script type="text/javascript">

		$(document).ready(function() {
			$.noConflict();
			$('#GEtable').DataTable( {
				dom: 'Bfrtip', 
				buttons: [
					'copy', 'csv', 'excel', 'pdf', 'print'
				]
				
			} );
		} );
   </script>

 <table id="GEtable" class="table table-striped table-bordered" cellspacing="0" width="100%">
  <thead>
  <tr>
    <th>ribozyme name</th>
    <th>Description </th>
    <th>First author</th>
    <th>Corresponding author</th>
    <th>Time</th>
    <th>reference</th>
    <th>Journal</th>
    <th>pubmed ID</th>
  </tr>
 </thead>
 <tbody>
  <tr>
    <td>twister ribozyme</td>
    <td>This article established an outstandingly flexible expression platform, which in conjugation with three different aptamer domains, enables the construction of many different one- and two-input regulators of gene expression in both bacteria and yeast.</td>
    <td>Felletti, M</td>
    <td>J. S. Hartig</td>
    <td>2016</td>
    <td>Twister ribozymes as highly versatile expression platforms for artificial riboswitches</td>
    <td>Nat Commun</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/27670347" target="_blank"><b>27670347</b></a></td>
  </tr>
</tbody>
</table>
</html>
<p><br /></p>

<blockquote>
  <p>Detection System</p>
</blockquote>

<p>Many ribozyme-based detection systems have been designed. For example, theophylline-dependent ribozymes can detect theophylline molecules in mammalian cells. Other detection targets, such as proteins or viruses, have also been designed. In addition, the temperature can be detected based on the self-cleavage ribozyme.<br /></p>

<html>

  <script type="text/javascript" src="https://code.jquery.com/jquery-3.5.1.js"></script>
	<script type="text/javascript" src="https://cdn.datatables.net/1.12.1/js/jquery.dataTables.min.js"></script>
	<script type="text/javascript" src="https://cdn.datatables.net/buttons/2.2.3/js/dataTables.buttons.min.js"></script>
	<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.1.3/jszip.min.js"></script>
	<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.1.53/pdfmake.min.js"></script>
	<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.1.53/vfs_fonts.js"></script>
	<script type="text/javascript" src="https://cdn.datatables.net/buttons/2.2.3/js/buttons.html5.min.js"></script>
	<script type="text/javascript" src="https://cdn.datatables.net/buttons/2.2.3/js/buttons.print.min.js"></script>
  <script type="text/javascript">

		$(document).ready(function() {
			$.noConflict();
			$('#DStable').DataTable( {
				dom: 'Bfrtip', 
				buttons: [
					'copy', 'csv', 'excel', 'pdf', 'print'
				]
				
			} );
		} );
   </script>
 <table id="DStable" class="table table-striped table-bordered" cellspacing="0" width="100%">
  <thead>
  <tr>
    <th>ribozyme name</th>
    <th>Description </th>
    <th>First author</th>
    <th>Corresponding author</th>
    <th>Time</th>
    <th>reference</th>
    <th>Journal</th>
    <th>pubmed ID</th>
  </tr>
 </thead>
<tbody>
   <tr>
    <td>hammerhead ribozyme</td>
    <td>This article reported the re-engineering of hammerhead ribozymes in order to respond efficiently to aminoglycoside antibiotics.</td>
    <td>Klauser, B</td>
    <td>J. S. Hartig</td>
    <td>2015</td>
    <td>Ribozyme-based aminoglycoside switches of gene expression engineered by genetic selection in S. cerevisiae</td>
    <td>ACS Synth Biol</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/24871672" target="_blank"><b>24871672</b></a></td>
  </tr>
</tbody>
</table>
</html>
<p><br /></p>

<blockquote>
  <p>Gene Editing system</p>
</blockquote>

<p>To overcome the uncontrolled nature of Cas9-gRNA complex cleavage activity in the current CRISPR/Cas9 system, several labs have designed ribozyme-induced gRNA release to achieve on-demand control of Cas9 activity.<br /></p>

<html>
  <script type="text/javascript" src="https://code.jquery.com/jquery-3.5.1.js"></script>
	<script type="text/javascript" src="https://cdn.datatables.net/1.12.1/js/jquery.dataTables.min.js"></script>
	<script type="text/javascript" src="https://cdn.datatables.net/buttons/2.2.3/js/dataTables.buttons.min.js"></script>
	<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.1.3/jszip.min.js"></script>
	<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.1.53/pdfmake.min.js"></script>
	<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.1.53/vfs_fonts.js"></script>
	<script type="text/javascript" src="https://cdn.datatables.net/buttons/2.2.3/js/buttons.html5.min.js"></script>
	<script type="text/javascript" src="https://cdn.datatables.net/buttons/2.2.3/js/buttons.print.min.js"></script>
  <script type="text/javascript">
		$(document).ready(function() {
			$.noConflict();
			$('#DEtable').DataTable( {
				dom: 'Bfrtip', 
				buttons: [
					'copy', 'csv', 'excel', 'pdf', 'print'
				]
				
			} );
		} );
   </script>
 <table id="DEtable" class="table table-striped table-bordered" cellspacing="0" width="100%">
  <thead>
  <tr>
    <th>ribozyme name</th>
    <th>Description </th>
    <th>First author</th>
    <th>Corresponding author</th>
    <th>Time</th>
    <th>reference</th>
    <th>Journal</th>
    <th>pubmed ID</th>
  </tr>
 </thead>
<tbody>
  <tr>
    <td>glmS ribozyme</td>
    <td>This article suggests the glmS ribozyme is a very suitable target for antibacterial drug development with antisense oligonucleotides.</td>
    <td>Traykovska, M</td>
    <td>R. Penchovsky</td>
    <td>2021</td>
    <td>Targeting glmS Ribozyme with Chimeric Antisense Oligonucleotides for Antibacterial Drug Development</td>
    <td>ACS Synth Biol</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/34734706" target="_blank"><b>34734706</b></a></td>
  </tr>
  <tr>
    <td>HDV ribozyme</td>
    <td>This article designed an improved CRISPR-Cas12a system included the Hepatitis delta virus (HDV) ribozyme  to facilitate accurate 3'-end processing of the crRNA transcript to produce precise molecules,which enhanced not only the gene editing efficiency, but also the activity of the catalytically inactive Cas12a-based CRISPR gene activation platform.</td>
    <td>Berkhout, B</td>
    <td>E. Herrera-Carrillo</td>
    <td>2021</td>
    <td>Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation</td>
    <td>Methods in Molecular Biology</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/32712922" target="_blank"><b>32712922</b></a></td>
  </tr>
  <tr>
    <td>group II intron</td>
    <td>This article provides the practical basis for potential applications of targeted group II introns in genetic engineering, functional genomics, and gene therapy.</td>
    <td>Guo, H</td>
    <td>A. M. Lambowitz</td>
    <td>2000</td>
    <td>Group II introns designed to insert into therapeutically relevant DNA target sites in human cells</td>
    <td>Science</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/10903206" target="_blank"><b>10903206</b></a></td>
  </tr>
  <tr>
    <td>group II intron</td>
    <td>This article used mobile group II introns to develop a targetron containing a retrotransposition-activated selectable marker (RAM), which enables one-step bacterial gene disruption at near 100% efficiency after selection.</td>
    <td>Zhong, J</td>
    <td>A. M. Lambowitz</td>
    <td>2003</td>
    <td>Targeted and random bacterial gene disruption using a group II intron (targetron) vector containing a retrotransposition-activated selectable marker</td>
    <td>Nucleic Acids Res</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/12626707" target="_blank"><b>12626707</b></a></td>
  </tr>
  <tr>
    <td>group II intron</td>
    <td>This article adapted a mutagenesis system based on the mobile group II intron from the ltrB gene of Lactococcus lactis (Ll.ltrB) to function in clostridial hosts.</td>
    <td>Heap, J. T</td>
    <td>N. P. Minton</td>
    <td>2007</td>
    <td>The ClosTron: a universal gene knock-out system for the genus Clostridium</td>
    <td>J Microbiol Methods</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/17658189" target="_blank"><b>17658189</b></a></td>
  </tr>
  <tr>
    <td>group II intron</td>
    <td>This article provides insight into modes of DNA target site recognition used by mobile group II introns.</td>
    <td>Zhuang, F</td>
    <td>A. M. Lambowitz </td>
    <td>2009</td>
    <td>EcI5, a group IIB intron with high retrohoming frequency: DNA target site recognition and use in gene targeting</td>
    <td>RNA</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/19155322" target="_blank"><b>19155322</b></a></td>
  </tr>
  <tr>
    <td>group II intron</td>
    <td>This article used an efficient mobile group II intron with an IEP lacking the En domain for the efficient recognition of DNA target sites at different locations in the Sinorhizobium meliloti chromosome.</td>
    <td>Garcia-Rodriguez, F. M</td>
    <td>N. Toro</td>
    <td>2014</td>
    <td>Use of the computer-retargeted group II intron RmInt1 of Sinorhizobium meliloti for gene targeting</td>
    <td>RNA Biol</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/24646865" target="_blank"><b>24646865</b></a></td>
  </tr>
  <tr>
    <td>RNase P</td>
    <td>This article uses a sequence-specific ribozyme (M1GS RNA) derived from the catalytic RNA subunit of RNase P from Escherichia coli  for inhibiting HCV replication and demonstrates the utility of this ribozyme for antiviral applications.</td>
    <td>Mao, X</td>
    <td>G. Li</td>
    <td>2014</td>
    <td>Inhibition of hepatitis C virus by an M1GS ribozyme derived from the catalytic RNA subunit of Escherichia coli RNase P</td>
    <td>Virology journal </td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/24885776" target="_blank"><b>24885776</b></a></td>
  </tr>
  <tr>
    <td>RNase P</td>
    <td>This study is the first to use a sequence-specific ribozyme (M1GS RNA) derived from the catalytic RNA subunit of RNase P for inhibiting human cytomegalovirus replication and demonstrates the utility of this ribozyme for antiviral applications.</td>
    <td>Trang, P</td>
    <td>F. Liu</td>
    <td>2000</td>
    <td>Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli</td>
    <td>Proc Natl Acad Sci U S A</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/10811889" target="_blank"><b>10811889</b></a></td>
  </tr>
  <tr>
    <td>hammerhead ribozyme</td>
    <td>This article reported the use of hammerhead ribozyme for the generation of gRNAs both in  vitro and in zebrafish embryos.</td>
    <td>Lee, R. T</td>
    <td>P. W. Ingham</td>
    <td>2016</td>
    <td>Ribozyme Mediated gRNA Generation for In Vitro and In Vivo CRISPR/Cas9 Mutagenesis</td>
    <td>PLoS One</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/27832146" target="_blank"><b>27832146</b></a></td>
  </tr>
  <tr>
    <td>hammerhead ribozyme</td>
    <td>This article developed tetracycline-dependent ribozymes, which can switch on gene expression up to 8.7-fold upon addition of tetracycline.</td>
    <td>Beilstein, K</td>
    <td>B. Suess</td>
    <td>2015</td>
    <td>Conditional control of mammalian gene expression by tetracycline-dependent hammerhead ribozymes</td>
    <td>ACS Synth Biol</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/25265236" target="_blank"><b>25265236</b></a></td>
  </tr>
  <tr>
    <td>hammerhead ribozyme</td>
    <td>This article develops an artificial gene named RGR that, once transcribed, generates an RNA molecule with ribozyme sequences at both ends of the designed gRNA, which can efficiently guide sequence-specific cleavage of DNA targets both in vitro and in yeast.</td>
    <td>Gao, Y</td>
    <td>Y. Zhao</td>
    <td>2014</td>
    <td>Self-processing of ribozyme-flanked RNAs into guide RNAs in vitro and in vivo for CRISPR-mediated genome editing</td>
    <td>J Integr Plant Biol</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/24373158" target="_blank"><b>24373158</b></a></td>
  </tr>
  <tr>
    <td>group II intron</td>
    <td>This article suggests retargeted group II introns can be used for highly specific chromosomal gene disruption in Escherichia coli and other bacteria.</td>
    <td>Karberg, M</td>
    <td>A. M. Lambowitz</td>
    <td>2001</td>
    <td>Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria</td>
    <td>Nat Biotechnol</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/11731786" target="_blank"><b>11731786</b></a></td>
  </tr>
  <tr>
    <td>group II intron</td>
    <td>This article shows mobile group II introns have been used to develop a novel class of gene targeting vectors, targetrons, which employ base pairing for DNA target recognition and can thus be programmed to insert into any desired target DNA.</td>
    <td>Zhong, J</td>
    <td>A. M. Lambowitz</td>
    <td>2003</td>
    <td>Targeted and random bacterial gene disruption using a group II intron (targetron) vector containing a retrotransposition-activated selectable marker</td>
    <td>Nucleic Acids Res</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/12626707" target="_blank"><b>12626707</b></a></td>
  </tr>
</tbody>
</table><br /><br />




</html>
:ET